ADC Program

About Lantern Pharma

Lantern Pharma is an AI-driven oncology company using its RADR® platform to streamline drug discovery and clinical development. The company has advanced a pipeline to Phase 2, focusing on biomarker-stratified patient populations to improve success rates and reduce costs. Its strategy centers on leveraging massive datasets and machine learning to reposition drug candidates and design more efficient clinical trials. Key achievements include building a significant data asset, advancing multiple programs into the clinic, and securing orphan drug designations.

Therapeutic Areas

Other Undisclosed solid tumors Drugs